Halozyme Therapeutics Statistics
Total Valuation
HALO has a market cap or net worth of $8.00 billion. The enterprise value is $9.86 billion.
| Market Cap | 8.00B |
| Enterprise Value | 9.86B |
Important Dates
The last earnings date was Monday, May 11, 2026, after market close.
| Earnings Date | May 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HALO has 118.61 million shares outstanding. The number of shares has decreased by -4.58% in one year.
| Current Share Class | 118.61M |
| Shares Outstanding | 118.61M |
| Shares Change (YoY) | -4.58% |
| Shares Change (QoQ) | +4.42% |
| Owned by Insiders (%) | 1.03% |
| Owned by Institutions (%) | 104.98% |
| Float | 117.28M |
Valuation Ratios
The trailing PE ratio is 23.74 and the forward PE ratio is 7.66.
| PE Ratio | 23.74 |
| Forward PE | 7.66 |
| PS Ratio | 5.30 |
| Forward PS | n/a |
| PB Ratio | 36.39 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 11.98 |
| P/OCF Ratio | 11.81 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.34, with an EV/FCF ratio of 14.76.
| EV / Earnings | 28.26 |
| EV / Sales | 6.53 |
| EV / EBITDA | 10.34 |
| EV / EBIT | 11.47 |
| EV / FCF | 14.76 |
Financial Position
The company has a current ratio of 2.76, with a Debt / Equity ratio of 9.91.
| Current Ratio | 2.76 |
| Quick Ratio | 2.14 |
| Debt / Equity | 9.91 |
| Debt / EBITDA | 2.26 |
| Debt / FCF | 3.26 |
| Interest Coverage | 44.97 |
Financial Efficiency
Return on equity (ROE) is 99.40% and return on invested capital (ROIC) is 28.62%.
| Return on Equity (ROE) | 99.40% |
| Return on Assets (ROA) | 22.06% |
| Return on Invested Capital (ROIC) | 28.62% |
| Return on Capital Employed (ROCE) | 37.21% |
| Weighted Average Cost of Capital (WACC) | 7.29% |
| Revenue Per Employee | $3.57M |
| Profits Per Employee | $824,688 |
| Employee Count | 423 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 2.20 |
Taxes
In the past 12 months, HALO has paid $154.53 million in taxes.
| Income Tax | 154.53M |
| Effective Tax Rate | 30.70% |
Stock Price Statistics
The stock price has increased by +29.64% in the last 52 weeks. The beta is 0.88, so HALO's price volatility has been lower than the market average.
| Beta (5Y) | 0.88 |
| 52-Week Price Change | +29.64% |
| 50-Day Moving Average | 65.58 |
| 200-Day Moving Average | 68.96 |
| Relative Strength Index (RSI) | 52.52 |
| Average Volume (20 Days) | 1,760,337 |
Short Selling Information
The latest short interest is 14.38 million, so 12.12% of the outstanding shares have been sold short.
| Short Interest | 14.38M |
| Short Previous Month | 14.26M |
| Short % of Shares Out | 12.12% |
| Short % of Float | 12.26% |
| Short Ratio (days to cover) | 10.27 |
Income Statement
In the last 12 months, HALO had revenue of $1.51 billion and earned $348.84 million in profits. Earnings per share was $2.84.
| Revenue | 1.51B |
| Gross Profit | 1.16B |
| Operating Income | 859.28M |
| Pretax Income | 503.37M |
| Net Income | 348.84M |
| EBITDA | 953.01M |
| EBIT | 859.28M |
| Earnings Per Share (EPS) | $2.84 |
Balance Sheet
The company has $318.62 million in cash and $2.18 billion in debt, with a net cash position of -$1.86 billion or -$15.67 per share.
| Cash & Cash Equivalents | 318.62M |
| Total Debt | 2.18B |
| Net Cash | -1.86B |
| Net Cash Per Share | -$15.67 |
| Equity (Book Value) | 219.64M |
| Book Value Per Share | 1.85 |
| Working Capital | 639.83M |
Cash Flow
In the last 12 months, operating cash flow was $677.42 million and capital expenditures -$9.76 million, giving a free cash flow of $667.65 million.
| Operating Cash Flow | 677.42M |
| Capital Expenditures | -9.76M |
| Depreciation & Amortization | 93.74M |
| Net Borrowing | 624.57M |
| Free Cash Flow | 667.65M |
| FCF Per Share | $5.63 |
Margins
Gross margin is 76.67%, with operating and profit margins of 56.96% and 23.13%.
| Gross Margin | 76.67% |
| Operating Margin | 56.96% |
| Pretax Margin | 33.37% |
| Profit Margin | 23.13% |
| EBITDA Margin | 63.18% |
| EBIT Margin | 56.96% |
| FCF Margin | 44.26% |
Dividends & Yields
HALO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 4.58% |
| Shareholder Yield | 4.58% |
| Earnings Yield | 4.36% |
| FCF Yield | 8.35% |
Analyst Forecast
The average price target for HALO is $85.44, which is 26.69% higher than the current price. The consensus rating is "Buy".
| Price Target | $85.44 |
| Price Target Difference | 26.69% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | -0.33% |
| EPS Growth Forecast (5Y) | 10.44% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on December 10, 2003. It was a forward split with a ratio of 4.275:1.
| Last Split Date | Dec 10, 2003 |
| Split Type | Forward |
| Split Ratio | 4.275:1 |
Scores
HALO has an Altman Z-Score of 3.92 and a Piotroski F-Score of 6.
| Altman Z-Score | 3.92 |
| Piotroski F-Score | 6 |